"At Mosaic Life Care, we are committed to providing the best and safest care, while creating a warm, inviting environment for our patients, family members and caregivers. Our innovative life-care model combines traditional health care and a focus on key life elements that affect overall wellness. It is our commitment to the health, well-being and vitality of the communities and organizations we serve through health-related initiatives and opportunities."

During the past decade, Saint Joseph Oncology Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 50 clinical trials were completed, i.e. on average, 2500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 19 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Oncology Inc" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "Gynecologic Oncology Group" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Celgene" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Oncology Inc" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Oncology Inc" are "Colorectal Cancer" (4 trials), "Ovarian Endometrioid Adenocarcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Stage IIA Fallopian Tube Cancer AJCC v6 and v7" (4 trials) and "Stage IIB Fallopian Tube Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "Saint Joseph Oncology Inc" in a lesser frequency.

Most popular intervention types in "Saint Joseph Oncology Inc" are "Drug" (67 trials), "Other" (45 trials), "Biological" (22 trials), "Procedure" (9 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (14 trials), "Bevacizumab" (13 trials), "Paclitaxel" (12 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Oncology Inc" are 57 trials for "All" genders, 19 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Oncology Inc". undefined are not yet recruiting, 1 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Saint Joseph Oncology Inc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Oncology Inc, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".